Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 44 (Search time: 0.131 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityColler, J.; Krebsfaenger, N.; Klein, K.; Wolbold, R.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2010The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivationHelsby, N.; Hui, C.; Goldthorpe, M.; Coller, J.; Soh, M.; Gow, P.; de Zoysa, J.; Tingle, M.
2003Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: An appraisal of in vitro studiesColler, J.
2001Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometryMurdter, T.; Coller, J.; Claviez, A.; Schonberger, F.; Hofmann, U.; Dreger, P.; Schwab, M.
2001Distribution of microsomal epoxide hydrolase in humans: An immunohistochemical study in normal tissues, and benign and malignant tumoursColler, J.; Fritz, P.; Zanger, U.; Siegle, I.; Eichelbaum, M.; Kroemer, H.; Murdter, T.
2002The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liverColler, J.; Krebsfaenger, N.; Klein, K.; Endrizzi, K.; Wolbold, R.; Lang, T.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2008TGFβ2 and TβRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cellsBuck, M.; Coller, J.; Murdter, T.; Eichelbaum, M.; Knabbe, C.
2012Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependenceColler, J.; Hutchinson, M.
2004CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesHutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.